Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat.About the Clinical Study. This Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Subjects with Hereditary …Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character Taryn R. Bagby1, Shuang Cai1, Shaofeng Duan1, Qiuhong Yang1, Sharadvi Thati1, Cory Berkland1, Daniel J. Aires2, and M. Laird Forrest1,* 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 2 Division of Dermatology, Dept. of Internal Medicine ...3307145. Contact Us About The Company Profile For Kinimmune, Inc. KINIMMUNE, INC. KANSAS FOREIGN FOR-PROFIT. WRITE REVIEW. Address: Cory Berkland 1117 E. 1264 Road Lawrence, KS 66947. Registered Agent: Cory Berkland.Christian Pharmacists Fellowship International (CPFI) unites pharmacists and pharmacy students working to incorporate their faith into the pharmacy profession. CPFI has chapters throughout the United States and offers members opportunities for community service, short or long term mission trips, bible studies and an annual national conference.pH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ...Kristin L. Aillon, Nashwa El-Gendy, Connor Dennis, Jeffrey P. Norenberg, Jacob McDonald and Cory Berkland . Iodinated NanoClusters as an Inhaled Computed Tomography Contrast Agent for Lung Visualization. Molecular Pharmaceutics 2010, 7 (4) , 1274-1282. DOI: 10.1021/mp1000718. Mark M. Bailey, Eric M. Gorman, Eric J. Munson and Cory Berkland . ...1. Introduction. Injectable scaffolds have received attention due to their potential for avoiding the invasive surgery typically required for tissue implantation. 1 From a clinical perspective, the use of injectable materials is an attractive alternative to surgery as it reduces the risk of infection, scar formation, patient discomfort and the cost of treatment. 2 Injectable scaffolds may be ...He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Citation: Dormer N, Berkland C, "Single-Step Functional Coatings for Increased Efficiencies". ONdrugDelivery Magazine, Issue 77 (Jul 2017), pp 28-31. In this article about oral drug innovation, Cory Berkland and Nathan Dormer focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of ...Cory Berkland, Departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA. E-mail: [email protected] Read the full textCory Berkland. E-mail: [email protected]; Vladimir Birman Associate Professor of Chemistry McMillen 409. E-mail: [email protected]; Phone: 314-935-9188 John BleekeCory Berkland. Connect About Experience Recommendations. Saint Louis, Missouri, United States. Interested in Entrepreneur Technologically Savvy. Orbis Biosciences - Aquired by Adare Pharmaceuticals in 2020 Savara Pharmaceuticals - NASDAQ listed in 2017. Experience.What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... Name Graduation Year/Degree Received Post-KU; Yusuf Adeshina: 2019 - Ph.D. Associate Director, VantAl, New York, NY: Adriana Altuve-Blanco: 2004 - Ph.D. Senior ...I, Cory J. Berkland, Ph.D., hereby declare as follows: I. INTRODUCTION 1. I am currently appointed as the Solon E. Summerfield Distinguished Professor in the Department of Pharmaceutical Chemistry and the Department of Chemical and Petroleum Engineering at the University of Kansas. I have been re-Nashwa El-Gendy, Mark M. Bailey, Cory Berkland; Pages 283-312. Liposomes for Pulmonary Drug Delivery. Janani Swaminathan, Carsten Ehrhardt; Pages 313-334. Nanoparticles for Pulmonary Delivery. Alan B. Watts, Robert O. Williams III; Pages 335-366. Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy.Brittany L. Hartwell, Chad J. Pickens, Martin Leon, and Cory Berkland . Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6) , 1893-1907. DOI: …Corresponding Author. [email protected]; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047 USA. E‐mail: [email protected]; [email protected] Search for more papers by this authorBiography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. Mark M Bailey 1 , Christine M Mahoney, Kassibla E Dempah, Jeffrey M Davis, Matthew L Becker, Supang Khondee, Eric J Munson, Cory Berkland Affiliation 1 Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047, USA; National Institute of Standards and Technology, 100 Bureau Drive, Mail Stop 8371 ...My research under Dr. Cory Berkland involved the development of an antigen-specific immunotherapy for multiple sclerosis. Specifically, I investigated the cell targeting properties and therapeutic ...Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Cory Berkland. 2008, Macromolecules. Heterogeneity of oil reservoirs often leads to unproductive cycling of injected oil recovery chemicals, resulting in the loss of significant quantities of reserves. To maximize recovery efficiency, a blocking agent may be placed deep into high-permeability channels so that the subsequently injected chemicals ...The main apparatus (Fig. 1A), which provides fabrication of monodisperse microparticles, is based on passing a solution containing the sphere material, and any drug to be encapsulated, through a small nozzle or other orifice (20 μm to a few millimeters in diameter) to form a smooth, cylindrical jet.To controllably break the jet into droplets, the nozzle is vibrated by a piezoelectric ...Cory Berkland PhD, VP Strategic Development. Kingdom Capital Portfolio Advisors. View fullsize.AU - Berkland, Cory. N1 - Funding Information: We gratefully acknowledge support from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (R56 AI091996), the National Institute of General Medical Sciences (T32 GM008359), the Kansas IDeA Network of Biomedical Research Excellence, the PhRMA Foundation ...Jun 6, 2017 · INTRODUCTION. Autoimmune diseases such as multiple sclerosis (MS) are typified by a breakdown of healthy immune regulation and subsequent misrecognition of self for non-self. 1–2 The autoimmune breakdown in MS is largely propagated by autoreactive T and/or B cell clonal expansion and attack against myelin sheath autoantigens, leading to demyelination and neurodegeneration. 3–6 Activation ... Fah Chueahongthong; Singkome Tima; Sawitree Chiampanichayakul; Cory Berkland; Songyot Anuchapreeda: 1-Sep-2021: Correction to: Effect of fluoroscopic X-rays combined with iodinated radiographic contrast media on human hematological parameters (Toxicology and Environmental Health Sciences, (2021), 13, 3, (225-235), 10.1007/s13530-021-00093-7)In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents. INTRODUCTION. Multiple sclerosis (MS) is a neurodegenerative disease characterized by an inflammatory reaction against proteins in the central nervous system (CNS) leading to nervous system dysfunction and paralysis (1-3).Several FDA-approved therapies exist to treat patients with MS; however, these therapies do not cure the disease but rather are designed to slow disease progression and ...Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KSSearch for more papers by this authorCory J. Berkland, Chairperson _____ Prajnaparamita Dhar, Co-advisor Date Approved: April 26, 2016 . iii Abstract Gene therapy has become a promising strategy for treatment of numerous diseases such as cancer, hemophilia, and neurodegenerative diseases. Glybera® (alipogene tiparvovec) became theCory Berkland Type 1 diabetes (T1D) is an autoimmune disorder which develops when insulin-producing, pancreatic beta cells are destroyed by an aberrant immune response.He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience.The toll-like receptor 7 and 8 (TLR7/8) agonist Resiquimod (R848) has been recognized as a promising immunostimulator for the treatment of cutaneous cancers in multiple clinical trials. However, systemic administration of R848 often results in strong immune-related toxicities while having limited th …El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752–1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731–2746.El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752–1763. [Europe PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731–2746.Dennis4, and Cory Berkland1,4,* 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence KS 66047 2Department of Pharmaceutics and Industrial Pharmacy, ... 864-1454, [email protected]. NIH Public Access Author Manuscript Mol Pharm. Author manuscript; available in PMC 2014 October 23.C. Berkland et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. J. Control. Release (2002) ... Cory Berkland. Protein Encapsulation in and Release from Monodisperse Double-Wall Polymer Microspheres. Journal of Pharmaceutical Sciences, Volume 102, Issue 5, 2013, pp. 1601-1609 ...Cory J Berkland from Lawrence, KS. Age: 46 years old. Also known as: Mr Cory Berkland, Cory Berkland, Mr Cory J Berkland. View Full Report . Mobile number (785) 764-0127 . Landline number (785) 838-3023 . Email addresses. [email protected]. [email protected] . Relatives. Jodi Berkland .Cory Berkland The University of Kansas Verified email at ku.edu. Stevin H. Gehrke University of Kansas Verified email at ku.edu. ... M Singh, L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010: Development and quantitative characterization of the precursor rheology of hyaluronic acid hydrogels for ...Founded Date Aug 31, 2016. Founders Cory Berkland. Operating Status Active. Last Funding Type Series B. Also Known As Bond Bio, Fetterex Biopharma. Legal Name Bond Biosciences, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 650-804-2139.Founded Date Aug 31, 2016. Founders Cory Berkland. Operating Status Active. Last Funding Type Series B. Also Known As Bond Bio, Fetterex Biopharma. Legal Name Bond Biosciences, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 650-804-2139.Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat.Dec 8, 2022. --. By Grant Downes, University Venture Fund-Crossroad, Intern. Dr. Jonny Miller, Ph.D., is an assistant research professor at the University of Kansas and co-founder of AxioForce ...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Cory Berkland has 3 current jobs including Co-founder and Chief Executive Officer at Bond Biosciences, Co-founder and Chief Scientific Officer at Bond Biosciences, and Solon E. Summerfield Distinguished Professor at University of Kansas. Additionally, Cory Berkland has had 1 past job as the Chief Science/Scientist at Orbis Biosciences.Cory J. Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, KS, 66045 USA. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, KS, 66047 USA. E-mail: [email protected] Search for more papers by this authorCory Berkland Jian QIAN Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2021-08-13 Filing date 2022-08-12 Publication date 2023-02-16Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourNanoparticles, Nanocapsules And Nanogels. Acid-labile poly (N-vinyl formamide) ("PNVF") nanocapsules were synthesized by free radical polymerization of N-vinyl formamide with optional active ingredients on the surface of silica nanoparticles. Polymerization in the presence of a novel cross-linker that contains an acid-labile ketal ...Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KansasName Graduation Year/Degree Received Post-KU; Yusuf Adeshina: 2019 - Ph.D. Associate Director, VantAl, New York, NY: Adriana Altuve-Blanco: 2004 - Ph.D. Senior ...Cory Berkland, The University of Kansas, Lawrence, Kansas, United States of America Akhilesh Bhambhani, Merck and Co Inc West Point, Doylestown, Pennsylvania, United States of America Michael Blaber, Florida State University, Tallahassee, Florida, United States of AmericaCory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand1.. IntroductionInjectable biomaterials that form three-dimensional (3-D) structures in situ are being pursued as tissue engineering scaffolds [1], biosensors [2] and drug delivery systems [3].Colloidal gels composed of oppositely-charged nanoparticles at high concentration can exhibit pseudoplastic behavior facilitating the fabrication of shape-specific macroscale materials with 3-D ...A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle.Previously, such CPP polyelectrolyte complexes were demonstrated as an efficient and non-cytotoxic means of gene delivery (Baoum et al., 2009, Baoum and Berkland, 2011). The use of calcium to condense CPP/pDNA complexes resulted in small particles leading to gene expression levels that were even higher than optimized PEI …Diaz is a scholar in the IMSD program and is mentored by Cory Berkland, Solon E. Summerfield Distinguished Professor. Jasmine Deng, of Shawnee, has a bachelor's degree in biochemistry from KU. Jasmine is a scholar in the PREP program and is mentored by Randolph Nudo, professor of molecular and integrative physiology, and Heather Hudson ...Cory Berkland. [email protected]; Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, Illinois 61801. Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, Illinois 61801. Telephone: 785-864-1455; Fax: 785-864-1454Search for more papers by this authorTY - JOUR. T1 - Monodisperse liquid-filled biodegradable microcapsules. AU - Berkland, Cory. AU - Pollauf, Emily. AU - Varde, Neel. AU - Pack, Daniel W.In addition, nanoparticle agglomerates revealed enhanced dissolution of the drug species suggesting the value of this formulation approach for poorly water soluble pulmonary medicines. Ultimately, nifedipine powders are envisioned as an approach to treat pulmonary hypertension. Keywords: drug delivery, nanoparticles, nifedipine, dry powder aerosol.Chad Groer 1 , Ti Zhang 1 , Ruolin Lu 2 , Shuang Cai 1 , Derek Mull 1 2 , Aric Huang 2 , Melanie Forrest 1 , Cory Berkland 2 3 , Daniel Aires 1 4 , Marcus Laird Forrest 1 2 Affiliations 1 HylaPharm LLC, 2029 Becker Dr, Lawrence, Kansas 66047, United States.Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Biography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry.Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...BERKLAND CORY, WANG QUN. Author information. Affiliations. All authors. 1. UNIV KANSAS Patent: Publ. of Application with search report - European Patent Office Application: EP20080848334 on 06 Nov 2008 Publication: 06 Nov 2008 PAT: EP2217295 . Patent. Share this article ...Purpose Encapsulation of liquids into biodegradable polymer microcapsules has been a challenging task due to production limitations stemming from solution viscosity, phase stabilization, molecular localization, and scalable production. We report an extension of Precision Particle Fabrication (PPF) technology for the production of monodisperse liquid-filled microcapsules containing an oil or ...Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate . Journal of Controlled Release . 2002 Jul 18;82(1):137-147. doi: 10.1016/S0168-3659(02)00136-Cory Berkland, distinguished professor of chemical and petroleum engineering. Lisa Friis, professor of mechanical engineering. Anil Misra, professor of civil, environmental and architectural engineering. Steven Soper, foundation distinguished professor of mechanical enginering and chemistry. Paulette Spencer, distinghuished professor of ...Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USACory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, …Cory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7.
Singkome Tima 1 , Siriporn Okonogi 2 , Chadarat Ampasavate 2 , Chad Pickens 3 , Cory Berkland 4 , Songyot Anuchapreeda 5 Affiliations 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand.. Garden city movie
1.. IntroductionInjectable biomaterials that form three-dimensional (3-D) structures in situ are being pursued as tissue engineering scaffolds [1], biosensors [2] and drug delivery systems [3].Colloidal gels composed of oppositely-charged nanoparticles at high concentration can exhibit pseudoplastic behavior facilitating the fabrication of shape-specific macroscale materials with 3-D ...Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition Chad J. Pickens1, Stephanie N. Johnson1, Melissa M. Pressnall1, Martin A. Leon2, and Cory J. Berkland1,2 1Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USATodd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.The objective of this work is to use colloidal gel from alginate-chitosan-PLGA complex to deliver Ac-PLP-BPI-NH 2-2 peptide in a controlled-release manner as a vaccine-like therapeutic to suppress experimental autoimmune encephalomyelitis (EAE) in the mouse model.Oppositely charged PLGA nanoparticles were prepared by a solvent diffusion method.Integrated Science Building (ISB) 1567 Irving Hill Road, Room 1140 Lawrence, KS 66045 [email protected] 785-864-4670Founded Date Aug 31, 2016. Founders Cory Berkland. Operating Status Active. Last Funding Type Series B. Also Known As Bond Bio, Fetterex Biopharma. Legal Name Bond Biosciences, Inc. Company Type For Profit. Contact Email [email protected]. Phone Number 650-804-2139.Emily C. Beck, Brooke L. Lohman, Daniel B. Tabakh, Sarah L. Kieweg, Stevin H. Gehrke, Cory J. Berkland, Michael S. Detamore. Enabling Surgical Placement of Hydrogels Through Achieving Paste-Like Rheological Behavior in Hydrogel Precursor Solutions. Annals of Biomedical Engineering 2015, 43 (10) , 2569-2576.Cory Berkland Songyot Anuchapreeda: Authors: Singkome Tima Siriporn Okonogi Chadarat Ampasavate Chad Pickens Cory Berkland Songyot Anuchapreeda: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 1-Dec-2016: Abstract:I would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland, for all of his support, guidance, patience, understanding, and most importantly, his friendship during my graduate studies at The University of Kansas. I have been fortunately blessed to have an advisor who gave me a great opportunity to develop my own individuality byNashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourSentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting polymer nanoprobes were designed and ...Jim Berkland. James O. Berkland (July 31, 1930 – July 22, 2016) was an American geologist [1] who controversially claimed to be able to predict earthquakes, including the 1989 Loma Prieta earthquake and 1994 Northridge Earthquake [2] and who popularized the idea that some people are earthquake sensitive. He was profiled in a popular 2006 book ...Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, …Emily C. Beck, Brooke L. Lohman, Daniel B. Tabakh, Sarah L. Kieweg, Stevin H. Gehrke, Cory J. Berkland, Michael S. Detamore. Enabling Surgical Placement of Hydrogels Through Achieving Paste-Like Rheological Behavior in Hydrogel Precursor Solutions. Annals of Biomedical Engineering 2015, 43 (10) , 2569-2576.Cory Berkland View MOF on the other hand, Wuttke and others (Ettlinger et al., 2022) argue that shape or topology might not have a major role to play in overall toxicity, citing a lack of evidence ...The average moduli of the scaffolds, determined from the stress–strain plots using the end of the initial linear regions before the onset of the nonlinear region (the rationale for this will explained later), ranged from 71 to 196 kPa (Fig. 3), which may be suitable for cartilage tissue engineering applications.A higher intrinsic viscosity of the …Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a part ial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourCory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab. 1. Introduction. The efficient delivery of therapeutic genes to a target site is a key to success in gene therapy. Viruses are very efficient gene vectors, but safety concerns such as immunogenicity of viral proteins and risk of oncogenesis still remain. 1 Non-viral vectors are continually under development and offer the potential for clinical application. 2 Cell penetrating peptides (CPPs ...Cory Berkland is a professor in the Engineering department at University of Kansas - see what their students are saying about them or leave a rating yourself. ... Professor Berkland's Top Tags. Test heavy Graded by few things. Check out Similar Professors in the . Engineering Department 5.00 Caroline Bennett; 5.00 James Stiles;.